SILENCE THERAPEUTICS PLC
Last · —$8.98+0.11 (+1.24%)live · yahoo · 0s ago
Market cap$558.14M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $43.3M |
|---|---|
| Operating income | $-63.3M |
| Net income | $-45.3M |
| Free cash flow | $-67.9M |
| Operating margin | -146.4% |
| Net margin | -104.7% |
| Return on equity | -33.8% |
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-05
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 1444.4%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -15851.9%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -11139.7%
- Cash Runway Low — Cash runway ~0.2 years
- Accumulated Deficit High — Accumulated deficit / equity 903%
- Rd Intensity High — R&D/Revenue 12120.4%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.09
Est. revenue
20,670
Earnings transcripts
- Issuer webcast
Q4 2023 webcast
SILENCE THERAPEUTICS PLC
- Issuer webcast
Q4 2022 webcast
SILENCE THERAPEUTICS PLC
- Issuer webcast
Q4 2024 webcast
SILENCE THERAPEUTICS PLC
- Issuer webcast
Q4 2020 earnings call transcript
SILENCE THERAPEUTICS PLC
- Issuer webcast
Q2 2020 earnings call transcript
SILENCE THERAPEUTICS PLC
- Issuer webcast
Q2 2021 webcast
SILENCE THERAPEUTICS PLC
Documents
FormReporting forFiledFlags